|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Division of Clinical Pharmacology and Section of Gastroenterology, Medizinische Klinik Innenstadt, University of Munich, Munich, Germany
It is widely believed that generation of mature dendritic cells (DCs) with full T cell stimulatory capacity from human monocytes in vitro requires 57 days of differentiation with GM-CSF and IL-4, followed by 23 days of activation. Here, we report a new strategy for differentiation and maturation of monocyte-derived DCs within only 48 h of in vitro culture. Monocytes acquire immature DC characteristics by day 2 of culture with GM-CSF and IL-4; they down-regulate CD14, increase dextran uptake, and respond to the inflammatory chemokine macrophage inflammatory protein-1
. To accelerate DC development and maturation, monocytes were incubated for 24 h with GM-CSF and IL-4, followed by activation with proinflammatory mediators for another 24 h (FastDC). FastDC expressed mature DC surface markers as well as chemokine receptor 7 and secreted IL-12 (p70) upon CD40 ligation in the presence of IFN-
. The increase in intracellular calcium in response to 6Ckine showed that chemokine receptor 7 expression was functional. When FastDC were compared with mature monocyte-derived DCs generated by a standard 7-day protocol, they were equally potent in inducing Ag-specific T cell proliferation and IFN-
production as well as in priming autologous naive T cells using tetanus toxoid as a model Ag. These findings indicate that FastDC are as effective as monocyte-derived DCs in stimulating primary, Ag-specific, Th 1-type immune responses. Generation of FastDC not only reduces labor, cost, and time required for in vitro DC development, but may also represent a model more closely resembling DC differentiation from monocytes in vivo.
This article has been cited by other articles:
![]() |
C. Stuehler, S. Mielke, M. Chatterjee, J. Duell, S. Lurati, F. Rueckert, H. Einsele, R. C. Bargou, and M. S. Topp Selective depletion of alloreactive T cells by targeted therapy of heat shock protein 90: a novel strategy for control of graft-versus-host disease Blood, September 24, 2009; 114(13): 2829 - 2836. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Martin, D. L. Kurkowski, A. M. Valentino, and F. Santiago-Schwarz Increased Intracellular, Cell Surface, and Secreted Inducible Heat Shock Protein 70 Responses Are Triggered during the Monocyte to Dendritic Cell (DC) Transition by Cytokines Independently of Heat Stress and Infection and May Positively Regulate DC Growth J. Immunol., July 1, 2009; 183(1): 388 - 399. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vukcevic, G. C. Spagnoli, G. Iezzi, F. Zorzato, and S. Treves Ryanodine Receptor Activation by Cav1.2 Is Involved in Dendritic Cell Major Histocompatibility Complex Class II Surface Expression J. Biol. Chem., December 12, 2008; 283(50): 34913 - 34922. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Elia, P. Cappello, M. Puppo, T. Fraone, C. Vanni, A. Eva, T. Musso, F. Novelli, L. Varesio, and M. Giovarelli Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine expression profile J. Leukoc. Biol., December 1, 2008; 84(6): 1472 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Botturi, Y. Lacoeuille, P. Thomas, S. Boniface, M. Reynaud-Gaubert, and A. Magnan CTLA-4-mediated regulatory phenotype of T-cells in tolerant lung recipients Eur. Respir. J., June 1, 2008; 31(6): 1167 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Seubert, E. Monaci, M. Pizza, D. T. O'Hagan, and A. Wack The Adjuvants Aluminum Hydroxide and MF59 Induce Monocyte and Granulocyte Chemoattractants and Enhance Monocyte Differentiation toward Dendritic Cells J. Immunol., April 15, 2008; 180(8): 5402 - 5412. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lotfi and M. T. Lotze Eosinophils induce DC maturation, regulating immunity J. Leukoc. Biol., March 1, 2008; 83(3): 456 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ricciardi, A. R. Elia, P. Cappello, M. Puppo, C. Vanni, P. Fardin, A. Eva, D. Munroe, X. Wu, M. Giovarelli, et al. Transcriptome of Hypoxic Immature Dendritic Cells: Modulation of Chemokine/Receptor Expression Mol. Cancer Res., February 1, 2008; 6(2): 175 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Landi, L. A. Babiuk, and S. van Drunen Littel-van den Hurk High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer J. Leukoc. Biol., October 1, 2007; 82(4): 849 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ito, A. Demachi-Okamura, R. Ohta, Y. Akatsuka, K. Nishida, K. Tsujimura, Y. Morishima, T. Takahashi, and K. Kuzushima Full-length EBNA1 mRNA-transduced dendritic cells stimulate cytotoxic T lymphocytes recognizing a novel HLA-Cw*0303- and -Cw*0304-restricted epitope on EBNA1-expressing cells J. Gen. Virol., March 1, 2007; 88(3): 770 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Peng, F.-c. Lin, P. H. Verardi, L. A. Jones, M. B. McChesney, and T. D. Yilma Pseudotyped Single-Cycle Simian Immunodeficiency Viruses Expressing Gamma Interferon Augment T-Cell Priming Responses In Vitro J. Virol., March 1, 2007; 81(5): 2187 - 2195. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Masten, G. K. Olson, C. A. Tarleton, C. Rund, M. Schuyler, R. Mehran, T. Archibeque, and M. F. Lipscomb Characterization of Myeloid and Plasmacytoid Dendritic Cells in Human Lung J. Immunol., December 1, 2006; 177(11): 7784 - 7793. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sanarico, A. Ciaramella, A. Sacchi, D. Bernasconi, P. Bossu, F. Mariani, V. Colizzi, and S. Vendetti Human monocyte-derived dendritic cells differentiated in the presence of IL-2 produce proinflammatory cytokines and prime Th1 immune response J. Leukoc. Biol., September 1, 2006; 80(3): 555 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dauer, K. Schad, J. Junkmann, C. Bauer, J. Herten, R. Kiefl, M. Schnurr, S. Endres, and A. Eigler IFN-{alpha} promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4 J. Leukoc. Biol., August 1, 2006; 80(2): 278 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Carnevale-Schianca, A. Cignetti, A. Capaldi, K. Vitaggio, A. Vallario, A. Ricchiardi, E. Sperti, R. Ferraris, M. Gatti, G. Grignani, et al. Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD Blood, May 1, 2006; 107(9): 3795 - 3803. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Nimura, L. F. Zhang, K. Okuma, R. Tanaka, H. Sunakawa, N. Yamamoto, and Y. Tanaka Cross-linking cell surface chemokine receptors leads to isolation, activation, and differentiation of monocytes into potent dendritic cells. Experimental Biology and Medicine, April 1, 2006; 231(4): 431 - 443. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Bagley, S. F. Abdelwahab, R. G. Tuskan, and G. K. Lewis Cholera Toxin Indirectly Activates Human Monocyte-Derived Dendritic Cells In Vitro through the Production of Soluble Factors, Including Prostaglandin E2 and Nitric Oxide Clin. Vaccine Immunol., January 1, 2006; 13(1): 106 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Herrmann, C. T. Morita, K. Lee, and D. J. Kusner Calmodulin kinase II regulates the maturation and antigen presentation of human dendritic cells J. Leukoc. Biol., December 1, 2005; 78(6): 1397 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Moghaddami, G. Mayrhofer, and L. G. Cleland MHC class II compartment, endocytosis and phagocytic activity of macrophages and putative dendritic cells isolated from normal tissues rich in synovium Int. Immunol., August 1, 2005; 17(8): 1117 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. K. Koski, K. Kariko, S. Xu, D. Weissman, P. A. Cohen, and B. J. Czerniecki Cutting Edge: Innate Immune System Discriminates between RNA Containing Bacterial versus Eukaryotic Structural Features That Prime for High-Level IL-12 Secretion by Dendritic Cells J. Immunol., April 1, 2004; 172(7): 3989 - 3993. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Bagley, S. F. Abdelwahab, R. G. Tuskan, and G. K. Lewis Calcium Signaling through Phospholipase C Activates Dendritic Cells To Mature and Is Necessary for the Activation and Maturation of Dendritic Cells Induced by Diverse Agonists Clin. Vaccine Immunol., January 1, 2004; 11(1): 77 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Curti, E. Ferri, S. Pandolfi, A. Isidori, R. M. Lemoli, M. Dauer, K. Schad, J. Herten, S. Endres, and A. Eigler Dendritic Cell Differentiation J. Immunol., January 1, 2004; 172(1): 3 - 4. [Full Text] [PDF] |
||||
![]() |
S. Xu, G. K. Koski, M. Faries, I. Bedrosian, R. Mick, M. Maeurer, M. A. Cheever, P. A. Cohen, and B. J. Czerniecki Rapid High Efficiency Sensitization of CD8+ T Cells to Tumor Antigens by Dendritic Cells Leads to Enhanced Functional Avidity and Direct Tumor Recognition Through an IL-12-Dependent Mechanism J. Immunol., September 1, 2003; 171(5): 2251 - 2261. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |